Skip to content
Calculadora Capital
JNJStocksNYSEUSD

Johnson & Johnson (JNJ): return calculator

Johnson & Johnson (JNJ) shares, a giant of medicines and medical devices, listed in New York.

US$231.29Latest price · 22 Jun 2026 close

Updated

Type
Stocks
Market
NYSE
Currency
USD
Sector
Healthcare
Data range
2016-07 – 2026-06 · 10 years
Source
Yahoo Finance

US$1,000 invested 9 years ago would be worth today

US$2,238

+123.8% total return

Try your own values in the calculators below.

Return calculator

Pick an amount and a period to see what an investment in Johnson & Johnson (JNJ) would be worth today. By default we include reinvested dividends (total return).

Lump sum

What a one-off investment would be worth today.

Value today
US$1,616
Total return
+61.6%
Annualised return
+10.1%

Monthly investing (DCA)

What investing the same amount every month would be worth.

Value today
US$9,003
Profit
US$2,903
Total invested
US$6,100

Estimate before taxes, fees and currency-conversion costs. Past performance does not guarantee future returns.

Investment growth

US$1,000US$2,428
Growth of US$1,000 invested — 2016-07 to 2026-06.

Performance

Annualised return
+9.36%
Best year (2025)
+47%
Worst year (2023)
-9%
Largest drop
-15.2%

Data for the last 10 years · 2016-07 → 2026-06

Comparison with the market

US$1,000 invested vs S&P 500 ETF (SPY):

Johnson & Johnson (JNJ)
US$2,428
S&P 500 ETF (SPY)
US$3,861

Johnson & Johnson (JNJ) trailed S&P 500 ETF (SPY) over this period.

Risk & drawdowns

The largest peak-to-trough drop in the window was -15.2%. An investor who bought near the prior peak would have seen the investment fall significantly before recovering.

Scenarios

Illustrative results based on the available data.

  • US$1,000 5 years ago

    US$1,616

    lump sum, +61.59804851900643% return

  • US$100/mo for 5 years

    US$9,003

    invested US$6,100

  • If it repeats +9.36%/yr for 10 years

    US$2,447

    projection from US$1,000 (hypothetical)

About Johnson & Johnson (JNJ)

Johnson & Johnson is one of the largest healthcare companies in the world, with two main businesses: pharmaceuticals (its largest source of revenue) and medical devices (the MedTech area, such as implants and surgical equipment). In 2023 it spun off its consumer-products business (band-aids, shampoos), which became a separate company called Kenvue.

It trades on the New York Stock Exchange (NYSE) under the ticker JNJ and is part of the S&P 500 and Dow Jones indices. It is a defensive stock and one of the "dividend kings", having raised its dividend for more than 60 years in a row. Because it sells healthcare, it tends to swing less than the market average, but it faces lawsuits and the loss of patents on important drugs.

Related calculators

Other assets

Frequently asked questions

How much did Johnson & Johnson (JNJ) return over the last 10 years?
+142.8% in total, or about +9.36% per year, on a total-return basis (dividends reinvested), between 2016-07 and 2026-06.
Do these calculations include dividends?
By default yes (total return). Turn off "include dividends" to see price-only appreciation.
Do they include taxes or fees?
No. These are estimates before taxes, broker fees and currency-conversion costs.
What currency are the values in?
USD. A euro-based investor also carries EUR/USD currency risk, not reflected here.
Does past performance predict the future?
No. Past performance does not guarantee future returns; this is educational information, not advice.

Sources & methodology

Prices: Yahoo Finance. Monthly series, total return (dividends reinvested). Data through 2026-06-22.

Total return assumes dividends are reinvested; you can turn that off to see price-only appreciation. Values are estimates before taxes, fees and currency-conversion costs.

Page generated and reviewed by the Calculadora Capital editorial team. Last updated 2026-06-22.